Systemic Treatment with GM1 Ganglioside Improves Survival and Function of Cryopreserved Embryonic Midbrain Grafted to the 6-Hydroxydopamine-Lesioned Rat Striatum
Authors:
- G.U. HöglingerGHG.U. Höglinger
- W.H. OertelWOW.H. Oertel
- C.D. EarlCEC.D. Earl
- 1 July 2000
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 164 (1) , 121-129
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current ApproachesCell Transplantation, 2000
- Apoptosis in Primary Cultures of E14 Rat Ventral Mesencephala: Time Course of Dopaminergic Cell Death and Implications for Neural TransplantationExperimental Neurology, 1999
- Apoptosis in Neuronal Development and Transplantation: Role of Caspases and Trophic FactorsExperimental Neurology, 1999
- Lazaroid-enhanced survival of grafted dopamine neurons does not increase target innervationNeuroReport, 1998
- Tirilazad Mesylate Increases Dopaminergic Neuronal Survival in thein OculoGrafting ModelExperimental Neurology, 1997
- LazaroidsDrugs, 1995
- Cryopreservation and storage of embryonic rat mesencephalic dopamine neurons for one year: comparison to fresh tissue in culture and neural graftsBrain Research, 1993
- Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitroDevelopmental Brain Research, 1988
- Ganglioside‐Induced Neuritogenesis: Verification That Gangliosides Are the Active Agents, and Comparison of Molecular SpeciesJournal of Neurochemistry, 1983
- Estimation of nuclear population from microtome sectionsThe Anatomical Record, 1946